Nivolumab (Optivo), Pembrolizumab are both PD-1 inhibitors. PD-1 is a checkpoint protein on immune cells that alerts them not to attack cells that express PD-L1. Some cancer cells express PD-L1, which enables them to ''switch off an immune system respon
Klonalität:
Monoclonal
Isotyp:
IgG4
Reinheit:
Purified from cell culture supernatant by affinity chromatography
Application Verdünnung:
ELISA 1:5000-10000, FACS 1:100
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten